General Information of Drug (ID: DMEHESA)

Drug Name
HP-5000
Indication
Disease Entry ICD 11 Status REF
Knee osteoarthritis FA01 Phase 3 [1]
Cross-matching ID
TTD ID
D3G8YH

References

1 ClinicalTrials.gov (NCT04683627) A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee. U.S.National Institutes of Health.